ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
Subscribe To Our Newsletter & Stay Updated
